MarketBeat on MSN
Vertex's Crinetics deal balances growth with integration risk
Key Points Interested in Vertex Pharmaceuticals Incorporated? Here are five stocks we like better. Vertex Pharmaceuticals ...
Vertex Pharmaceuticals Incorporated VRTX on Monday agreed to acquire Crinetics Pharmaceuticals Inc. CRNX for $85 per share in ...
Vertex Pharmaceuticals Incorporated’s $10B Crinetics Pharmaceuticals, Inc. buy adds PALSONIFY & a Phase 3 CAH asset. Click ...
Vertex, Inc. reported its first-quarter financial results for 2025, showing total revenues of $177.1 million, a 12.9% year-over-year increase, driven by a 14.4% rise in software subscription revenues.
Vertex, Inc. will announce Q4 2024 financial results on February 27, 2025, with a conference call at 8:30 a.m. ET. Vertex, Inc., a leading provider of indirect tax solutions, announced it will release ...
Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) will report its first-quarter earnings on Monday. As the company reports after market hours, Wall Street expects $4.32 in EPS and $2.85 billion in revenues.
Vertex, Inc. (NASDAQ:VERX), a leading provider of enterprise compliance technology for global commerce, today announced that ...
With strong upside potential, Vertex, Inc. (NASDAQ:VERX) ranks among the overlooked tech stocks to invest in now.
Good day, and welcome to the Vertex Fourth Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Joe ...
Vertex (VERX) market outlook \| earnings revisions, market trends, long-term upside potential. Vertex Inc. (VERX) shares ...
Detailed price information for Vertex Inc Cl A (VERX-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results